Arc Raiders developer Embark Studios recently introduced a mysterious map modifier to the extraction shooter, and players are ...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no ...

Jo Firestone is a comedian and writer who loves games. Her favorite Crossword is the Sunday puzzle, even though it takes her ...

New information emerges that suggests Embark Studios may be gearing up to release new ARC Raiders content much sooner than ...

Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in ...

Daily Russian attacks on energy infrastructure have left residents of the Ukrainian capital without electricity and heating ...

ARC Raiders developer Embark says it is working on multiple new maps for its hit extraction shooter, as the studio finally ...

That "Enemy Forces" bit is important, since it stops some sweatily-optimised, out-of-bounds-jumping, breakneck route from ...

Ocugen Inc (NASDAQ:OCGN) shares are up on Friday as the company is gaining traction following positive market sentiment.

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

If you want to add a bit of dimension to your old fashioned or margarita, consider adding a splash of this bubbly booze. Here ...

Klein then hired his own medical expert, Dr. Mark Taylor, who came back with a much higher number: 15 percent. That rating ...